Kardiologie up2date 2011; 7(2): 125-139
DOI: 10.1055/s-0030-1256618
Aortenerkrankungen

© Georg Thieme Verlag KG Stuttgart · New York

Nierenarterienstenose

Thomas  Zeller, Elias  Noory, Aljoscha  Rastan
Further Information

Publication History

Publication Date:
21 July 2011 (online)

Abstract

Atherosclerotic renal artery stenosis (aRAS) is a disease of the advanced age and may result in deterioration of blood pressure control, renal function and myocardial dysfunction. Since the implementation of stenting endovascular treatment has replaced surgical revascularisation. The benefit of endovascular treatment of aRAS was challenged by the results of the STAR and ASTRAL trials resulting in similar outcomes of revascularisation and conservative treatment. However, these trial results can only be applied to a small proportion of the affected patients due to severe limitations of the both trial designs. Proper indication for renal stenting is the key for clinical success of the endovascular procedure. Most relevant is the identification of the hemodynamically relevance of the lesion by non-invasive (duplex) and invasive (pressure gradient) methods. Moreover, recently some clinical success predictors had been identified which are not yet sufficiently implemented in the decision making process. Unquestioned is the indication for revascularisation in RAS of single functioning kidneys, severe bilateral lesions and in each kind of RAS of non-atherosclerotic nature.

Kernaussagen

  • Die arteriosklerotische Nierenarterienstenose (aNAS) ist eine Erkrankung des höheren Lebensalters, die u. a. die Blutdruckeinstellung verschlechtern, die Nierenfunktion beeinträchtigen und zur myokardialen Dysfunktion führen kann.

  • Seit Einführung der Stentimplantation hat die Angioplastie die Gefäßchirurgie als Therapie der Wahl abgelöst. Der Nutzen revaskularisierender Maßnahmen auf die Verbesserung der Blutdruckkontrolle und die Nierenfunktion ist seit Publikation der ASTRAL- und STAR-Studien umstritten. Allerdings wird bei den Diskussionen häufig missachtet, dass die genannten Studienergebnisse nur auf einen kleinen Teil der betroffenen Patienten übertragen werden können.

  • Essenziell für einen klinischen Behandlungserfolg der Revaskularisation ist die korrekte Indikationsstellung, wesentlich dabei der Nachweis der hämodynamischen Relevanz einer Stenose durch nicht invasive (Duplexsonografie) und invasive Methoden (Druckgradientenmessung). Zudem existieren einige klinische Prädiktoren, denen bei der Therapieentscheidung noch zu selten Beachtung geschenkt wird.

  • Unbestritten ist die Indikation zur Revaskularisation bei hämodynamisch relevanten Stenosen funktioneller Einzelnieren, bilateraler Stenose und jeder Form einer relevanten Stenose nicht arteriosklerotischer Genese.

Literatur

  • 1 Caps M T, Zierler R E, Polissar N L et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis.  Kidney Int. 1998;  53 735-742
  • 2 Zierler R E, Bergelin R O, Davidson C D et al. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis.  AJH. 1996;  9 1055-1061
  • 3 Van Jaarsveld B C, Krijnen P, Pieterman H et al for the Dutch Renal Artery Stenosis Intervention Cooperative Study Group. The Effect of Balloon Angioplasty on Hypertension in Atherosclerotic Renal-Artery Stenosis.  N Engl J Med. 2000;  342 1007-1014
  • 4 Webster J, Marshall F, Abdalla M et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group.  J Hum Hypertens. 1998;  12 329-335
  • 5 Safian R D, Textor S C. Renal-artery stenosis.  N Engl J Med. 2001;  344 431-442
  • 6 Appel R G, Bleyer A J, Reavis S, Hansen K. Renovascular disease in older patients beginning renal replacement therapy.  Kidney Int. 1993;  48 171-176
  • 7 Andersen U B, Borglykke A, Joslashrgensen T. Prevalence of renal artery stenosis in subjects with moderate hypertension. A population-based study.  Blood Press. 2010;  [Epub ahead of print]
  • 8 Zeller T, Frank U, Späth M. Farbduplexsonographische Darstellbarkeit von Nierenarterien und Erkennung hämodynamisch relevanter Nierenarterienstenosen.  Zeitschr Ultraschall Med. 2001;  22 116-121
  • 9 Zeller T. Endovascular Treatment of Renal Artery Stenosis: Technical Aspects, Long-Term Clinical Results and Restenosis-Rate.. In: Marco J, Serruys P, Biamino G, Fajadet J, de Feyter P, Morice M C The Paris Course on Revascularization; 2001: 419-450
  • 10 Harding M B, Smith L R, Himmelstein S I et al. Prevalence and associated risk factors in patients undergoing routine cardiac catheterization.  J Am Soc Nephrol. 1992;  2 1608
  • 11 Conlon P J, Higgins R M, Walters H L et al. Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease.  QJM. 1994;  87 413-421
  • 12 Zeller T, Müller C, Frank U et al. Survival after stent-angioplasty of severe atherosclerotic ostial renal artery stenoses.  J Endovasc Ther. 2003;  10 539-545
  • 13 Chi Y W, White C J, Thornton S, Milani R V. Ultrasound velocity criteria for renal in-stent restenosis.  J Vasc Surg. 2009;  50(1) 119-123
  • 14 Zeller T, Frank U, Müller C, Bürgelin K et al. Duplex ultrasound for follow-up examination after stent-angioplasty of ostial renal artery stenoses.  Zeitschr Ultraschall Med. 2002;  23 315-319
  • 15 Zeller T, Bonvini R F, Rastan A, Sixt S. Colour-Coded Duplex Ultrasound for Diagnosis of Renal Artery Stenosis and as Follow-up Examination after Revascularization.  Cath Cardiovasc Intervent. 2008;  71 995-999
  • 16 May A G, De Weese J A, Rob C G. Hemodynamic effects of arterial stenosis.  Surgery. 1962;  53 513-524
  • 17 Parienty I, Rostoker G, Jouniaux F. et al . Renal Artery Stenosis Evaluation in Chronic Kidney Disease Patients: Nonenhanced Time-Spatial Labeling Inversion-Pulse Three-dimensional MR Angiography with Regulated Breathing versus DSA.  Radiology. 2011;  [Epub ahead of print]
  • 18 Hricik D E, Browning P J, Kopelman R et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or stenosis in a solitary kidney.  N Engl J Med. 1983;  308 373-376
  • 19 Plouin P F, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trail. The EMMA-study group.  Hypertension. 1998;  31 823-829
  • 20 The ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis.  N Engl J Med. 2009;  361 1953-1962
  • 21 Bax L, Woittiez A-J J, Kouwenberg H J et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function A randomized trial.  Ann Intern Med. 2009;  150 840-848
  • 22 Bavbek N, Kasapoglu B, Isik A et al. Olmesartan associated with acute renal failure in a patient with bilateral renal artery stenosis.  Ren Fail. 2010;  32(9) 1115-1117
  • 23 Keddis M T, Garovic V D, Bailey K R et al. Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates.  Nephrol Dial Transplant. 2010;  25 3615-3522
  • 24 Balzer K M, Pfeiffer T, Rossbach S et al. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD).  J Vasc Surg. 2009;  49(3) 667-675
  • 25 Ham S W, Kumar S R, Wang B R et al. Late outcomes of endovascular and open revascularization for nonatherosclerotic renal artery disease.  Arch Surg. 2010;  145(9) 832-839
  • 26 Van de Veen P JG, Kaatee R, Beutler J J et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial.  Lancet. 1999;  353 282-286
  • 27 Nordmann A J, Woo K, Parkes R, Logan A G. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials.  Am J Med. 2003;  114 44-50
  • 28 Kalra P A, Chrysochou C, Green D et al. The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease.  Cath Cardiovasc Intervent. 2010;  75 1-10
  • 29 Zeller T, Rastan A, Schwarzwälder U et al. Regression of left ventricular hypertrophy following stenting of renal artery stenosis.  JEVT. 2007;  14 189-197
  • 30 Dieter R S, Darki A, Nanjundappa A et al. Usefulness of wide pulse pressure as a predictor of poor outcome after renal artery angioplasty and stenting.  Am J Cardiol. 2009;  104(5) 732-734
  • 31 Ronden R A, Houben A J, Kessels A G et al. Predictors of clinical outcome after stent placement in atherosclerotic renal artery stenosis: a systematic review and meta-analysis of prospective studies.  J Hypertens. 2010;  28 2370-2377
  • 32 Staub D, Zeller T, Trenk D et al. Use of B-Type Natriuretic Peptide to Predict Blood Pressure Improvement after Percutaneous Revascularisation for Renal Artery Stenosis.  Eur J Vasc Endovasc Surg. 2010;  40 599-607
  • 33 Kapoor N, Fahsah I, Karim R et al. Physiological assessment of renal artery stenosis: Comparisons of resting with hyperemic renal pressure measurements.  Catheter Cardiovasc Interv. 2010;  76 726-732
  • 34 Mangiacapra F, Trana C, Sarno G et al. Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension.  Circ Cardiovasc Interv. 2010;  3(6) 537-542 Comment in: 526–527

Prof. Dr. Thomas Zeller

Herz-Zentrum Bad Krozingen
Abteilung Angiologie

Südring 15
79189 Bad Krozingen

Email: thomas.zeller@herzzentrum.de

    >